Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather M Long

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2019
Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4<sup>+</sup> T CellsBenjamin J Meckiff, Kristin Ladell, James E McLaren, et al.
Frontiers in Immunology|November 19, 2019
Non-uniform <i>in vivo</i> Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative DiseaseDavid M Burns, Gordon B Ryan, Caroline M Harvey, et al.
Plos Pathogens|March 14, 2009
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkGemma L Kelly, Heather M Long, Julianna Stylianou, et al.
BMJ Open|October 21, 2023
Immunology of THymectomy And childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-transplant lymphoproliferative disease (PTLD) in thymectomised childrenUgonna T Offor, Paolo Hollis, Milos Ognjanovic, et al.
Journal for Immunotherapy of Cancer|July 14, 2018
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignanciesVanessa M Tubb, Deborah S Schrikkema, Nathan P Croft, et al.
The Journal of Experimental Medicine|April 10, 2013
MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 responseHeather M Long, Odette L Chagoury, Alison M Leese, et al.
Journal of Virology|April 12, 2012
Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200Karen Misstear, Simon A Chanas, S A Rahim Rezaee, et al.
Cell Reports|July 20, 2023
Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4<sup>+</sup> T cell immunityYuan Chen, Georgina H Mason, D Oliver Scourfield, et al.
Hepatology (Baltimore, Md.)|April 18, 2012
Recruitment mechanisms of primary and malignant B cells to the human liverShishir Shetty, Tony Bruns, Christopher J Weston, et al.
Blood Advances|October 5, 2020
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphomaNenad Sejic, Lindsay C George, Rosemary J Tierney, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2019
Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4<sup>+</sup> T CellsBenjamin J Meckiff, Kristin Ladell, James E McLaren, et al.
Frontiers in Immunology|November 19, 2019
Non-uniform <i>in vivo</i> Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative DiseaseDavid M Burns, Gordon B Ryan, Caroline M Harvey, et al.
Plos Pathogens|March 14, 2009
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkGemma L Kelly, Heather M Long, Julianna Stylianou, et al.
BMJ Open|October 21, 2023
Immunology of THymectomy And childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-transplant lymphoproliferative disease (PTLD) in thymectomised childrenUgonna T Offor, Paolo Hollis, Milos Ognjanovic, et al.
Journal for Immunotherapy of Cancer|July 14, 2018
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignanciesVanessa M Tubb, Deborah S Schrikkema, Nathan P Croft, et al.
The Journal of Experimental Medicine|April 10, 2013
MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 responseHeather M Long, Odette L Chagoury, Alison M Leese, et al.
Journal of Virology|April 12, 2012
Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200Karen Misstear, Simon A Chanas, S A Rahim Rezaee, et al.
Cell Reports|July 20, 2023
Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4<sup>+</sup> T cell immunityYuan Chen, Georgina H Mason, D Oliver Scourfield, et al.
Hepatology (Baltimore, Md.)|April 18, 2012
Recruitment mechanisms of primary and malignant B cells to the human liverShishir Shetty, Tony Bruns, Christopher J Weston, et al.
Blood Advances|October 5, 2020
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphomaNenad Sejic, Lindsay C George, Rosemary J Tierney, et al.
Pageof 5